+34 620 10 75 37info@nanbiosis.com
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 13 Jul NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER– in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally[...] 02 Jul NANBIOSIS Unit 20 validated a light-activated cancer therapy in a breast cancer model, supporting a promising strategy to target resistant tumor cells. Barcelona, July 2026 — Researchers have demonstrated a promising photopharmacology strategy that uses light to selectively activate an anti-cancer compound,[...] 13 Jul NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER– in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally[...] 02 Jul NANBIOSIS Unit 20 validated a light-activated cancer therapy in a breast cancer model, supporting a promising strategy to target resistant tumor cells. Barcelona, July 2026 — Researchers have demonstrated a promising photopharmacology strategy that uses light to selectively activate an anti-cancer compound,[...] 13 Jul NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER– in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally[...] 02 Jul NANBIOSIS Unit 20 validated a light-activated cancer therapy in a breast cancer model, supporting a promising strategy to target resistant tumor cells. Barcelona, July 2026 — Researchers have demonstrated a promising photopharmacology strategy that uses light to selectively activate an anti-cancer compound,[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Welcome to Nanbiosis - Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Latest From the Blog
Resolution of the last competitive call of 2026 for access to NANBIOSIS
NANBIOSIS Supports Preclinical Validation of Light-Activated Therapy Against Resistant Breast Cancer Cells
Resolution of the last competitive call of 2026 for access to NANBIOSIS
NANBIOSIS Supports Preclinical Validation of Light-Activated Therapy Against Resistant Breast Cancer Cells
Resolution of the last competitive call of 2026 for access to NANBIOSIS
NANBIOSIS Supports Preclinical Validation of Light-Activated Therapy Against Resistant Breast Cancer Cells
Units of Nanbiosis
About Nanbiosis
Responsive Design
It has never been easier to setup your website. With intuitive page builder and clear instructions, your site will be live in no time.
HiDPi Ready
With retina images, Shard looks crisp and sharp across the whole specter of devices. Simply Gorgeous!
Drag’n’drop builder
Shard is written with best code practices to date. This makes it preform well on all modern browsers and devices of all sizes
